Skip to content

Neonatal Pulse Oximetry Sensor Study

Accuracy and Precision of Peripheral Capillary Oxygen Saturation of Reprocessed Pulse Oximetry Sensors Compared to Oxygen Saturation in Arterial Blood Samples Assessed by CO-oximetry in Neonates

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05250102
Enrollment
23
Registered
2022-02-22
Start date
2022-06-13
Completion date
2023-10-10
Last updated
2024-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Birth

Brief summary

To validate the SpO2 accuracy, bias, and precision of Medline's reprocessed pulse oximetry sensors as compared to SaO2 in arterial blood samples as assessed by CO-oximetry in neonates.

Detailed description

Pulse oximetry helps in measuring peripheral capillary oxygen saturation (SpO2) continuously and non-invasively, and provides an indirect measurement of arterial oxygenation (SaO2) based on the red and infrared light-absorption characteristics of oxygenated and deoxygenated hemoglobin. Uses of pulse oximetry include detection of hypoxia, avoidance of hyperoxia, titration of fractional inspired oxygen, and enabling weaning from mechanical ventilation. Arterial blood gas (ABG) analysis, such as by the use of CO-oximeter, provides a direct measurement of SaO2. However, ABG analysis requires time, expense, and arterial access. Therefore, this study aims to validate the SpO2 accuracy of pulse oximetry sensors (manufactured by Nellcor and Masimo, and reprocessed by Medline Industries, LP) in neonates as compared to ABG measurements as part of their clinical standard of care (SOC), as assessed by CO-oximetry.

Interventions

DEVICEPulse oximeter sensors

Pulse oximeter reading will be compared to CO-oximeter reading.

Sponsors

Medline Industries
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Days to 28 Days
Healthy volunteers
No

Inclusion criteria

* Subjects who are postnatal 28 days or younger (neonates) * Subjects who are likely to receive one or more ABG measurements as part of their clinical SOC * Subjects who weigh less than 5 Kg (weight range for thesensors)

Exclusion criteria

* Subjects with current signs and symptoms of a clinically significant Patent Ductus Arteriosus (PDA) combined with a current or planned arterial line placement which will affect the validity of the co-oximetry measurement * Subjects with physical malformation of hands, fingers, feet, or toes that would limit the ability to place sensors for this study * Subjects judged by the Principal Investigator (PI) to be inappropriate for participation in this study * Subjects for whom placing a pulse oximeter will cause dermatological issues (e.g. allergic to foam rubber or adhesive tape)

Design outcomes

Primary

MeasureTime frameDescription
Bland-Altman Analysis for Nellcor Pulse Oximeter15 episodic minutesBIAS Measurement and 95% confidence interval calculated using a Bland-Altman plot (mean vs. difference of SaO2 and SpO2) and an error plot (SaO2 vs. difference of SaO2 and SpO2) were generated. The B&A plot analysis is a simple way to evaluate a bias between the mean differences, and to estimate an agreement interval, within which 95% of the differences of the second method, compared to the first one, fall. Data can be analyzed both as unit differences plot and as percentage differences plot. We ran a percentage mean difference plot.

Countries

United States

Participant flow

Recruitment details

a total of 23 neonates were recruited for the study, with 1-3 measurement pairs taken for each subject and each pulse oximetry sensor, for a total of 2, 4, or 6 measurement pairs per subject.

Participants by arm

ArmCount
Pulse Oximeter Sensor Readings
Subjects who satisfy all of the inclusion criteria will be eligible to participate in the study, will receive intervention (the Masimo and Nellcor sensors, and their arterial blood sample will be taken in the normal course of care). This is a single arm study. Those who don't meet the inclusion/ exclusion criteria won't be eligible to participate. Pulse oximeter sensors: Pulse oximeter reading will be compared to CO-oximeter reading.
23
Total23

Baseline characteristics

CharacteristicPulse Oximeter Sensor Readings
Age, Categorical
<=18 years
23 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
Age, Continuous23.6 Weeks
STANDARD_DEVIATION 1.6
Race/Ethnicity, Customized
Black or African American
14 Participants
Race/Ethnicity, Customized
Hispanic or Latino
1 Participants
Race/Ethnicity, Customized
White - Non Hispanic or Latino
8 Participants
Sex: Female, Male
Female
17 Participants
Sex: Female, Male
Male
6 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 23
other
Total, other adverse events
0 / 23
serious
Total, serious adverse events
0 / 23

Outcome results

Primary

Bland-Altman Analysis for Nellcor Pulse Oximeter

BIAS Measurement and 95% confidence interval calculated using a Bland-Altman plot (mean vs. difference of SaO2 and SpO2) and an error plot (SaO2 vs. difference of SaO2 and SpO2) were generated. The B&A plot analysis is a simple way to evaluate a bias between the mean differences, and to estimate an agreement interval, within which 95% of the differences of the second method, compared to the first one, fall. Data can be analyzed both as unit differences plot and as percentage differences plot. We ran a percentage mean difference plot.

Time frame: 15 episodic minutes

Population: all neonates participating in the study

ArmMeasureGroupValue (MEAN)
Sensor Massimo or NellcorBland-Altman Analysis for Nellcor Pulse OximeterBias Massimo.151 percentage of difference in mean
Sensor Massimo or NellcorBland-Altman Analysis for Nellcor Pulse OximeterBias Nellcor.434 percentage of difference in mean

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026